MXPA05013720A - Linea de celula y sus usos. - Google Patents
Linea de celula y sus usos.Info
- Publication number
- MXPA05013720A MXPA05013720A MXPA05013720A MXPA05013720A MXPA05013720A MX PA05013720 A MXPA05013720 A MX PA05013720A MX PA05013720 A MXPA05013720 A MX PA05013720A MX PA05013720 A MXPA05013720 A MX PA05013720A MX PA05013720 A MXPA05013720 A MX PA05013720A
- Authority
- MX
- Mexico
- Prior art keywords
- cell line
- agonists
- receptor
- mch
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Electrotherapy Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Data Exchanges In Wide-Area Networks (AREA)
Abstract
La presente invencion se refiere a una linea de celula novedosa denominada como T42402I3.4.2, y a los usos de esta linea de celula. Por ejemplo, la linea de celula se puede utilizar en la produccion de proteina de receptor de hormona de concentracion de melanina (MCHR) y en la identificacion de antagonistas, agonistas inversos y agonistas para el receptor.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/463,123 US7252992B2 (en) | 2003-06-17 | 2003-06-17 | Cell line and uses thereof |
| PCT/US2004/018836 WO2004113511A2 (en) | 2003-06-17 | 2004-06-15 | Cell line and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05013720A true MXPA05013720A (es) | 2006-03-13 |
Family
ID=33517042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05013720A MXPA05013720A (es) | 2003-06-17 | 2004-06-15 | Linea de celula y sus usos. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7252992B2 (es) |
| EP (1) | EP1633859B1 (es) |
| JP (1) | JP4612629B2 (es) |
| AT (1) | ATE409740T1 (es) |
| CA (1) | CA2529882C (es) |
| CY (1) | CY1108643T1 (es) |
| DE (1) | DE602004016846D1 (es) |
| DK (1) | DK1633859T3 (es) |
| ES (1) | ES2314447T3 (es) |
| MX (1) | MXPA05013720A (es) |
| PL (1) | PL1633859T3 (es) |
| PT (1) | PT1633859E (es) |
| SI (1) | SI1633859T1 (es) |
| WO (1) | WO2004113511A2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006104136A1 (ja) * | 2005-03-29 | 2006-10-05 | Banyu Pharmaceutical Co., Ltd. | 非アルコール性脂肪性肝疾患の治療剤、及び非アルコール性脂肪性肝疾患の治療又は予防のための薬剤の候補化合物のスクリーニング方法 |
| EP2748316B1 (en) | 2011-10-17 | 2018-12-19 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
| WO2013057141A2 (en) | 2011-10-17 | 2013-04-25 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
| EP3129478B1 (en) | 2014-04-10 | 2019-03-27 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
-
2003
- 2003-06-17 US US10/463,123 patent/US7252992B2/en not_active Expired - Fee Related
-
2004
- 2004-06-15 JP JP2006517252A patent/JP4612629B2/ja not_active Expired - Fee Related
- 2004-06-15 DK DK04776530T patent/DK1633859T3/da active
- 2004-06-15 ES ES04776530T patent/ES2314447T3/es not_active Expired - Lifetime
- 2004-06-15 DE DE602004016846T patent/DE602004016846D1/de not_active Expired - Lifetime
- 2004-06-15 CA CA2529882A patent/CA2529882C/en not_active Expired - Fee Related
- 2004-06-15 PL PL04776530T patent/PL1633859T3/pl unknown
- 2004-06-15 SI SI200430970T patent/SI1633859T1/sl unknown
- 2004-06-15 PT PT04776530T patent/PT1633859E/pt unknown
- 2004-06-15 WO PCT/US2004/018836 patent/WO2004113511A2/en active Application Filing
- 2004-06-15 MX MXPA05013720A patent/MXPA05013720A/es active IP Right Grant
- 2004-06-15 EP EP04776530A patent/EP1633859B1/en not_active Expired - Lifetime
- 2004-06-15 AT AT04776530T patent/ATE409740T1/de active
-
2008
- 2008-12-10 CY CY20081101443T patent/CY1108643T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL1633859T3 (pl) | 2009-03-31 |
| SI1633859T1 (sl) | 2009-02-28 |
| CA2529882C (en) | 2014-05-20 |
| DK1633859T3 (da) | 2009-01-12 |
| CY1108643T1 (el) | 2014-04-09 |
| EP1633859A2 (en) | 2006-03-15 |
| US7252992B2 (en) | 2007-08-07 |
| WO2004113511A2 (en) | 2004-12-29 |
| US20040259194A1 (en) | 2004-12-23 |
| ES2314447T3 (es) | 2009-03-16 |
| DE602004016846D1 (de) | 2008-11-13 |
| JP2006527985A (ja) | 2006-12-14 |
| PT1633859E (pt) | 2009-01-09 |
| WO2004113511A3 (en) | 2005-04-28 |
| ATE409740T1 (de) | 2008-10-15 |
| CA2529882A1 (en) | 2004-12-29 |
| EP1633859B1 (en) | 2008-10-01 |
| JP4612629B2 (ja) | 2011-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200401591A1 (ru) | Керамические аноды и способ их изготовления | |
| EP2284191A3 (en) | Process for the preparation of hGH | |
| IL154589A0 (en) | Membrane penetrating peptides and uses thereof | |
| RS50966B (sr) | Agonisti pyy i njihova upotreba | |
| CL2007002948A1 (es) | Hidratos del compuesto 2-cloro-5-(3,6-dihidro-3-metil-2,6-dioxo-4-(trifluorometil)-1-(2h)-pirimidinil)-4-fluor-n-((metil(1-metiletil)amino)sulfonil]benzamida; proceso para la preparacion de dicho hidrato; composicion fitoprotectora; y metodo para con | |
| EP1389209A4 (en) | FOLAT MIMETICS AND THEIR FOLAT RECEPTOR BINDING CONJUGATES | |
| HK1074670A1 (en) | Sets of digital antibodies directed against short epitopes, and methods using same | |
| IL195338A (en) | An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use | |
| MX2010004687A (es) | Derivados de queratina y metodos de hacer los mismos. | |
| TW200635919A (en) | Novel processes for the preparation of CGRP-receptor antagonists and intermediates thereof | |
| WO2005028497A3 (en) | Receptor binding peptides derived from the sars s protein | |
| CY1108643T1 (el) | Κυτταρικη σειρα και χρησεις της | |
| MX2010010213A (es) | Peptido parcial de lacritina. | |
| WO2004081043A3 (en) | Baff mutants with at least one amino acid substitution and methods of their production | |
| TR200400639T4 (tr) | Donmaya-karşı proteinler, bunların üretimleri ve kullanımları | |
| DK1363944T3 (da) | Höjaffinitetsantagonister for ELR-CXC-kemokiner | |
| WO2003059281A3 (en) | Novel variants of rankl protein | |
| WO2003074656A3 (en) | Rank-ligand-induced sodium/proton antiporter polypeptides | |
| WO2004003133A3 (en) | Pain signaling molecules | |
| DE602004030899D1 (de) | Neues screening-verfahren | |
| DE602005018369D1 (de) | Neue proteine, z.b. zur verwendung für die in-vitro-isolierung und prävention von legionella pneumophila-infektionen | |
| WO2003082320A1 (fr) | Nouveau procede de criblage | |
| GEP20084464B (en) | Mutated neublastin | |
| AU2003239333A1 (en) | The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof | |
| EP1559721A4 (en) | NOVEL LIGANDS FPRL1 AND USES THEREOF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| GB | Transfer or rights |